<<Disclaimer: Verify this information before applying it to your situation.>>

Hi All,

Thank you so much to all of you who registered for the Gluten in Medications
Educational Session that will be held tomorrow at 11:30amEST! Due to the
overwhelming response to participate in the session, we have changed to a
different service to allow up to 2,000 people to attend. Please follow the
instructions below to ensure that you are entered into the new system and
will receive the necessary log-in instructions. We apologize for any
inconvenience this may cause. Thank you so much for understanding and we
look forward to your participation in the session tomorrow!

If you have any questions or concerns, please contact me at any time at
215-692-2639 or by email at [log in to unmask]
*Thanks!
Vanessa
*
-- 
Vanessa Maltin
Director of Programming & Communications
National Foundation for Celiac Awareness
4300 Montgomery Ave
Suite 102
Bethesda, MD 20814
484-362-2678 ext. 103
215-692-2639 cell
[log in to unmask]
www.celiaccentral.org
*

Gluten in Medications*
Join us for a Webinar on Friday September 12

Reserve your Webinar seat now at:
https://www1.gotomeeting.com/register/627658975


*Title:*
Gluten in Medications

*Date:*
Friday, September 12, 2008

*Time:*
11:30 AM - 1:00 PM EDT

*Overview:*
Approximately 3 million Americans may have celiac disease, an autoimmune
disorder triggered by the consumption of gluten, a protein found in wheat,
barley, and rye. The Food Allergen Labeling Consumer Protection Act of
2004, which requires packaged food labels to name all ingredients
containing wheat and other common allergens, was a major landmark for
patients with celiac disease and food allergens. Yet no similar
requirement exists for medication labels.

On Friday, September 12, Stop & Shop, in collaboration with the National
Foundation for Celiac Awareness, will host a Gluten in Medications
Education Session, sponsored by the American Society of Health-System
Pharmacists.

The 1.5 hour CE program will focus on educating pharmacists, other medical
professionals and the public about celiac disease, the issues of gluten in
medication, and how celiac disease may affect normal absorption of both
prescription and non-prescription drugs.

*Who should attend: *Pharmacists who practice in hospitals and health
systems, community pharmacies, chain and grocery stores pharmacies; as
well as pharmaceutical company representatives, national pharmacy
organizations, medical professionals, and others interested in learning
more about this topic.

*Learning objectives:*
Upon completion of the CE program, attendees will be able to: define
celiac disease and its pathophysiology; articulate the suspected incidence
of celiac disease; List signs and symptoms; describe potential sources of
gluten in medication; identify reactions celiac patients may have from
drugs; describe current United States and International guidelines for
labeling; and discuss ways that pharmacists and pharmaceutical
manufacturers can help patients with celiac disease use medicines safely.

*Welcome:*
Alice Bast, Executive Director, National Foundation for Celiac Awarness

What is Celiac Disease?
Dr. Daniel Leffler, Director of Clinical Research, The Celiac Center at Beth
Israel Deaconess Medical Center

Gluten in Medication & When is Gluten-Free Really Gluten-Free?
Priti N. Patel, PharmD, BCPS, Clinical Professor of the St. Johns University
College of Pharmacy

Excipients & Stakeholders
Gerry McEvoy, ASHP vice president, drug information

Parallels with the Food Allergen Labeling and Consumer Protection Act  & What
You Can Do to Help Celiac Patients
Vanessa Maltin, NFCA Director of Programming & Communications

Visit the Celiac Web Page at Http://www.enabling.org/ia/celiac/index.html
Archives are at: Http://Listserv.icors.org/SCRIPTS/WA-ICORS.EXE?LIST=CELIAC